Top 10 Companies in the Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure Market (2026): Market Leaders Driving Innovation in Surgical Closure

MARKET INSIGHTS

The global Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market size was valued at USD 0.85 billion in 2025. The market is projected to grow from USD 0.90 billion in 2026 to USD 1.55 billion by 2034, exhibiting a CAGR of 7.0% during the forecast period.

Cyanoacrylate (CA) instant adhesives for medical skin closure, commonly known by the brand name Dermabond, are specialized tissue adhesives designed to close surgical incisions and lacerations without the need for traditional sutures or staples. These medical‑grade formulations, primarily based on 2‑octyl cyanoacrylate, polymerize rapidly upon contact with moisture on the skin surface to form a strong, flexible bond that creates a waterproof microbial barrier.

While the broader medical adhesives sector continues to expand, this specific segment benefits from the growing preference for minimally invasive wound closure solutions that reduce procedure time, minimize scarring, and lower infection risks compared to conventional methods. Furthermore, advancements in biocompatible cyanoacrylate technologies have enhanced flexibility and handling characteristics, making them suitable for dynamic areas of the body and diverse surgical applications ranging from general surgery to cosmetic procedures. However, challenges such as proper application technique remain important for optimal outcomes.

The market is experiencing steady growth due to several factors, including the rising volume of surgical procedures worldwide, increasing adoption in outpatient and ambulatory settings, and a shift toward patient‑friendly closure options that improve cosmetic results and comfort. Additionally, ongoing innovations by leading manufacturers continue to refine product performance, supporting broader clinical acceptance across hospitals, clinics, and trauma care environments. Johnson & Johnson (Ethicon), through its Dermabond portfolio, remains a prominent player alongside other innovators offering high‑quality medical cyanoacrylate solutions.

Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market – View in Detailed Research Report

Top 10 Companies in the Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure Market (2026)

10. Ethicon (Johnson & Johnson MedTech)

Headquarters: Irvine, California, USA
Key Offering: Dermabond 2‑Octyl Cyanoacrylate, Dermabond Prineo Mesh System

Ethicon has long been the benchmark for tissue adhesives, leveraging its extensive surgical portfolio to embed Dermabond into standard operating room workflows. The brand’s focus on safety and user‑friendly applicators has made it the go‑to solution for surgeons seeking rapid closure without suture removal.

Sustainability & Growth Initiatives:

• Investment in biocompatible polymer research to reduce cytotoxicity.
• Expansion of global manufacturing sites to lower carbon footprint.
• Partnerships with academic centers to validate new indications.

9. B. Braun SE

Headquarters: Melsungen, Germany
Key Offering: Histoacryl 2‑Octyl Cyanoacrylate, Histoacryl Flex

B. Braun’s adhesive line emphasizes versatility across surgical specialties, with formulations tailored for high‑tension areas and pediatric applications. The company’s modular packaging supports point‑of‑care use in both tertiary hospitals and outpatient centers.

Sustainability & Growth Initiatives:

• Adoption of recyclable applicator casings.
• Digital training modules for proper technique.
• Strategic acquisitions to broaden product range.

8. Medtronic

Headquarters: Dublin, Ireland
Key Offering: Exofin 2‑Octyl Cyanoacrylate, Exofin Flex

Medtronic’s adhesive portfolio is integrated into its broader wound‑care ecosystem, providing a seamless transition from device to closure. The Exofin line is designed for use in minimally invasive procedures and high‑mobility sites.

Sustainability & Growth Initiatives:

• Research into antimicrobial additives.
• Global supply‑chain optimization for cost efficiency.
• Collaboration with regulatory bodies for streamlined approvals.

7. Advanced Medical Solutions Group plc

Headquarters: London, United Kingdom
Key Offering: AMS 2‑Octyl Cyanoacrylate, AMS Mesh System

AMS focuses on niche indications such as reconstructive surgery and trauma care, offering high‑viscosity formulations that provide superior control in complex wounds.

Sustainability & Growth Initiatives:

• Development of biodegradable adhesive variants.
• Expansion into emerging markets through joint ventures.
• Investment in AI‑driven application guidance tools.

6. Chemence Medical, Inc.

Headquarters: Irvine, California, USA
Key Offering: Chemence 2‑Octyl Cyanoacrylate, Chemence Flex

Chemence’s product line is distinguished by its focus on high‑performance formulations for dermatologic and plastic surgery, where cosmetic outcomes are paramount.

Sustainability & Growth Initiatives:

• Investment in green chemistry for polymer synthesis.
• Partnerships with cosmetic surgery societies for clinical trials.
• Digital marketplace for product ordering and support.

5. H.B. Fuller Company

Headquarters: Tulsa, Oklahoma, USA
Key Offering: H.B. Fuller Cyanoacrylate, H.B. Fuller Mesh Adhesive

After acquiring Medifill Ltd., H.B. Fuller has strengthened its position in the medical adhesive segment, focusing on high‑viscosity and flexible formulations that reduce skin irritation.

Sustainability & Growth Initiatives:

• Recyclable applicator design.
• Global sustainability reporting aligned with GRI standards.
• Investment in R&D for antimicrobial coatings.

4. Adhezion Biomedical

Headquarters: Irvine, California, USA
Key Offering: Adhezion 2‑Octyl Cyanoacrylate, Adhezion Flex

Adhezion Biomedical’s portfolio is tailored for high‑mobility and high‑tension applications, with a strong emphasis on user ergonomics and product consistency.

Sustainability & Growth Initiatives:

• Eco‑friendly packaging solutions.
• Participation in global wound‑care standards initiatives.
• Continuous improvement of application devices.

3. Meril Life Sciences Pvt. Ltd.

Headquarters: Hyderabad, India
Key Offering: Meril 2‑Octyl Cyanoacrylate, Meril Mesh System

Meril leverages its strong presence in the Indian market to provide affordable, high‑quality adhesives that meet local regulatory requirements while maintaining international safety standards.

Sustainability & Growth Initiatives:

• Localized manufacturing to reduce transportation emissions.
• Community outreach programs on wound‑care best practices.
• Strategic partnerships with regional hospitals.

2. Resivant Medical LLC

Headquarters: New York, New York, USA
Key Offering: Resivant 2‑Octyl Cyanoacrylate, Resivant Flex

Resivant focuses on high‑performance adhesives for emergency and trauma care, offering rapid set times and robust barrier properties.

Sustainability & Growth Initiatives:

• Investment in low‑toxicity polymer chemistry.
• Digital compliance tracking for regulatory submissions.
• Expansion of product line to include antimicrobial additives.

1. Johnson & Johnson (Ethicon)

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Dermabond 2‑Octyl Cyanoacrylate, Dermabond Prineo, Dermabond Flex

Johnson & Johnson’s Ethicon division remains the cornerstone of the market, with a broad portfolio that spans from standard surgical closures to advanced mesh‑integrated systems. The company’s focus on continuous improvement and global distribution keeps it ahead of emerging competitors.

Sustainability & Growth Initiatives:

• Commitment to net‑zero carbon emissions by 2050.
• Investment in biodegradable adhesive formulations.
• Global clinical trials to support new indications.

Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market – View in Detailed Research Report

Outlook

The CA instant adhesive market is set to maintain a steady upward trajectory, driven by the need for faster, scar‑minimizing closure solutions across both elective and emergency settings. The forecast to USD 1.55 billion by 2034 reflects the continued adoption of advanced formulations and the expansion of outpatient surgical models. Companies that invest in biocompatibility, flexible viscosities, and integrated mesh systems will capture the largest share of this evolving landscape.

Future Trends

Key trends shaping the next decade include:

• Development of antimicrobial and anti‑infection coatings to further reduce post‑operative complications.
• Integration of digital tools—such as application‑guidance apps—to standardize technique and improve outcomes.
• Expansion into emerging markets where surgical volumes are rising, supported by local manufacturing and cost‑effective product lines.
• Increased focus on sustainability, with recyclable applicators and biodegradable polymers becoming standard expectations.
• Regulatory alignment across regions, facilitating faster market entry for next‑generation adhesives.

Cyanoacrylate (CA) Instant Adhesive for Medical Skin Closure (Dermabond) Market – View in Detailed Research Report